StonvexLoading…
StonvexCore line items from GRNT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $450.31M | $380.03M | $394.07M | $497.42M |
Operating Income | $46.42M | $59.26M | $90.59M | $302.14M |
Net Income | $24.35M | $18.76M | $81.10M | $262.34M |
EPS (Diluted) | $0.18 | $0.14 | $0.61 | $1.97 |
Total Assets | $1.17B | $1.04B | $927.10M | $794.78M |
Total Liabilities | $562.31M | $401.13M | $255.46M | $130.53M |
Cash & Equivalents | $14.85M | $9.42M | $10.73M | $51.13M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 130.50M | 130.23M | 133.11M | 133.07M |